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Abstract
Background: Annual recording of the Royal College of Physicians three questions (RCP3Q) morbidity score is rewarded within the UK
‘pay-for-performance’ Quality and Outcomes Framework.
Aims: To investigate the performance of the RCP3Q for assessing control in real-life practice compared with the validated Asthma Control
Questionnaire (ACQ) administered by self-completed questionnaire.  
Methods: We compared the RCP3Q score extracted from a patient’s computerised medical record with the ACQ self-completed after the
consultation. The anonymous data were paired by practice, age, sex, and dates of completion. We calculated the sensitivity and specificity
of the RCP3Q scale compared with the threshold for good/poor asthma control (ACQ >1).   
Results: Of 291 ACQ questionnaires returned from 12 participating practices, 129 could be paired with complete RCP3Q data. Twenty-
five of 27 patients who scored zero on the RCP3Q were well controlled (ACQ <1). An RCP3Q score >1 predicted inadequate control (ACQ
>1) with a sensitivity of 0.96 and specificity of 0.34. Comparable values for RCP3Q>2 were sensitivity 0.50 and specificity 0.94. The
intraclass correlation coefficient of 0.13 indicated substantial variability between practices. Exacerbations and use of reliever inhalers were
moderately correlated with ACQ (Spearman’s rho 0.3 and 0.35) and may reflect different aspects of control.  
Conclusions: In routine practice, an RCP3Q score of zero indicates good asthma control and a score of 2 or 3 indicates poor control. An
RCP3Q score of 1 has good sensitivity but poor specificity for suboptimal control and should provoke further enquiry and consideration
of other aspects of control such as exacerbations and use of reliever inhalers.  
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Introduction 
Objective assessment of current clinical control and future risk is the
foundation of a routine asthma review, inviting consideration of the
reasons for poor control and underpinning the subsequent
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development of management plans.1,2 Asthma control can be defined
in a number of ways3 but, in primary care, important components are
the presence of symptoms (assessed by asking specific morbidity
questions), use of relief medication, and occurrence of exacerbations
(normally recorded in the patient’s healthcare record). Routinely
assessing and recording the results of standardised questions (Patient
Reported Outcome Measures, PROMS) has therefore been promoted
by initiatives to improve standards of clinical practice,4,5 including
within the Quality and Outcome Framework (QOF) a ‘pay-for-
performance scheme’ in the UK.6
PROMS in research and clinical practice       
The well-defined process for developing and validating PROMs7 is
exemplified by the widely used Asthma Control Questionnaire
(ACQ)8,9 which has defined scores that represent well and poorly
controlled asthma to aid clinical interpretation.3,10 Validity, however,
needs to be assessed in relation to a specific purpose and setting.7
In a research context, instruments validated for the relevant context
are chosen11 and administered by trained researchers using
techniques which maximise the response rate and reduce
completion errors.12 Use in the context of clinical care, however,
introduces a range of poorly understood variables including the
influence of diverse modes of administration and potential under- or
over-reporting of symptoms by patients anticipating the response
from their clinician. It cannot therefore be assumed that even the
best validated PROM will deliver valid answers when used in routine
clinical care.
The Royal College of Physicians three questions
(RCP3Q): a PROM designed for use in clinical
practice        
The RCP3Q (Table 1) emerged from a UK consensus meeting of
representatives of primary and secondary care and patient
organisations as a clinical tool which ‘made sense to both clinician
and patient’ and would be ‘widely used to improve standards of
care’.13,14 Precursors of the RCP3Q (the Tayside Asthma Stamp and
the Jones morbidity index) had been used in audits of asthma
management15 by postal questionnaire to predict asthma
exacerbations16,17 and, more recently, during telephone consultations
to screen for patients who might benefit from a face-to-face
review.18 When administered formally within a battery of
questionnaires in a prospective observational study of 20 adults
assessed 2-weekly for 12 weeks, there was a highly significant
correlation between the RCP3Q and the ACQ (0.79, p<0.001) and
a strong relationship between changes in both the scores.19
In the UK, annual recording of the RCP3Q has been introduced
as an essential component of an annual asthma review within the
QOF.6 This multicentre study aimed to investigate the performance
of the RCP3Qs in a real-life practice setting compared with the gold
standard of the ACQ administered by self-completed questionnaire,
and to examine the additional predictive value of other contextual
data. 
Methods 
Our validation study was undertaken during 2009-2011 in practices
throughout the UK. Ethical approval was granted by North West 4
Research Ethics Committee (Reference 09/H1001/103) and
governance approval was provided by the participating National
Health Service (NHS) Trusts.   
Practice recruitment   
We approached the 30 practices participating in the QOF pilot (in
which all potential QOF indicators are tested for reliability, validity,
and feasibility)20 and, with the support of the local Primary Care
Research Networks, extended recruitment to other practices in these
areas. Practices were eligible if they provided proactive asthma care
(usually led by an asthma trained nurse) during which they routinely
recorded the RCP3Qs. We specifically asked nurses not to change
their normal practice. 
Patient recruitment    
Participating practices were given between 20 and 40
questionnaires to distribute (according to list size), with additional
questionnaires provided on request. Adults (18 years or over) with
asthma were recruited as they attended the practice asthma clinic.
The only exclusion criteria were people with other significant
respiratory disease, those unable to complete a questionnaire in
English, or at the discretion of the clinician for significant medical or
social reasons. 
Data collection and handling    
All data were obtained anonymously.   
ACQ
At the end of the consultation, eligible patients were invited (by the
asthma nurse or other member of the practice team) to complete
the study questionnaire which was returned in a prepaid envelope
to the research team. The questionnaire included:
• The validated ACQ (6-question version).9 The ACQ measures
clinical goals of asthma management including use of reliever
medication on a scale of 0 (good control) to 6 (poor control).9
The threshold between ‘well controlled’ and ‘not well
controlled’ asthma is close to 1.00.10
• Identifiers: name of practice, demographic details (age and sex),
date of completion.
RCP3Qs
All the routinely recorded answers to the RCP3Q recorded in the
practice during the time they were participating in the study were
extracted using an automated search of the practice database
(Optimum Patient Care (OPC), Norfolk, UK
www.optimumpatientcare.org). The individual patient level data
included:
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In the last month
1 Have you had difficulty sleeping because of Yes/No
asthma symptoms (including cough)?
2 Have you had your usual asthma symptoms Yes/No
during the day (cough, wheeze, chest 
tightness or breathlessness)?
3 Has your asthma interfered with your usual Yes/No
activities (e.g. housework, work, school, etc)?
The ‘yes/no’ responses are scored with 1 for each positive answer 
giving a total score between 0 and 3.
Table 1. The Royal College of Physicians three questions13
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• Identifiers: practice code, demographic details (age and sex),
date of completion.
• The RCP3Qs as recorded on the practice computer. In the
absence of standardised coding, practices were asked how they
normally coded the responses to the questions and the search
modified appropriately. 
• Asthma drugs prescribed in the previous year.
• Acute exacerbations coded in the records.
Data handling
The RCP3Q and data from records were extracted electronically to a
database held by OPC. The ACQ was entered onto a separate
database at the University of Edinburgh. The RCP3Q and ACQ
entries were matched if the practice, age, and sex were identical and
if the dates of completion were within 24 hrs. In the event of two
pairs of records with the same identifiers, both were discarded. 
Sample size calculation  
Based on the potential availability of up to 30 practices from the
QOF pilot we estimated, using simulated data, that for a sensitivity
and specificity of approximately 0.8 with confidence intervals of
±0.075, we would require a sample size of approximately 250
patients.    
Statistical analysis   
We calculated the sensitivity and specificity of each level of the
RCP3Q scale compared with the validated ACQ threshold score of
>1 and plotted a receiver operating characteristic (ROC) curve,
taking an area under the curve (AUC) of >0.8 to indicate good
discrimination by the RCP3Q. We undertook additional analyses
using ACQ thresholds of ≤0.75 (the optimal cut-off point to be
confident that a patient has well controlled asthma6) and >1.5 (the
optimal cut-off point to be confident that the patient has
inadequately controlled asthma10). We examined variation between
practices by making scatter plots of RCP3Q against ACQ for each
practice. Statistical analysis was carried out in R 2.11 (R Foundation
for Statistical Computing, Vienna, Austria). 
Results
Twelve practices took part in the study; their details are shown in
Table 2. During the study period these practices recorded items from
the RCP3Q for a total of 916 patients. We provided a total of 360
questionnaires to the practices although it is likely that not all were
distributed; 291 questionnaires were returned of which 139 could be
paired with RCP3Q responses extracted from the practice computers.
The flow diagram shown in Figure 1 gives details of the process of
pairing. Ten patients were excluded because either the ACQ or
RCP3Q was incomplete. The remaining 129 patients from the 12
practices had valid ACQ and RCP3 scores and were thus included in
the subsequent analysis. The number of patients per practice ranged
from 2 to 28. The mean (SD) age of the patients was 54 (17) years
and 55 (43%) patients were male. The age, sex, and ACQ score of
the 152 patients whose questionnaires could not be reliably paired
were similar to those included in the analysis. 
Questionnaire responses   
The ACQ scores ranged from 0 to 5 with a mean (SD) of 1.08 (1.03).
The RCP scores ranged from 0 to 3 with a mean (SD) of 1.14 (0.86)
and median of 1. Table 3 compares the distribution of scores for the
two scales and shows that 25/27 patients (92.5%) with an RCP3Q
score of zero had an ACQ score <1 indicating ‘well controlled
asthma’. In contrast, an ACQ score of >1 indicating ‘not well
controlled asthma’ was recorded by 26/70 patients (37.1%) with an
RCP3Q score of 1 and by 28/32 patients (87.5%) with an RCP3Q
score of 2 or 3. 
Diagnostic accuracy of RCP3Q and ACQ  
The diagnostic accuracy of the RCP score was measured against the
ACQ threshold value of 1.0 (the defined crossover point between
‘well controlled’ and ‘not well controlled’ asthma).10 With a cut-off
RCP3Q score of >1, the sensitivity was 0.96 (95% CI 0.88 to 0.99)
and specificity 0.34 (95% CI 0.24 to 0.46) while, with a cut-off
RCP3Q score of >2, the sensitivity was 0.50 (95% CI 0.37 to 0.63)
and the specificity was 0.94 (95% CI 0.87 to 0.98). These values are
summarised in the ROC curve shown in Figure 2; the AUC was 0.79
(95% CI 0.75 to 0.81). The sensitivity and specificity of the RCP3Q
compared with three different ACQ thresholds are shown in Table 4. 
Relationship of RCP3Q score to good and poor control   
An RCP3Q score of zero was recorded for 27 patients: only one of
Practice ID PCRN Number of GPs Number of asthma Total list size Proportion with active asthma*
nurses N (%)
1† Manchester 2 1 4,227 251 (5.9)
2† Somerset 5 2 5,407 314 (5.8)
5† London 5 1 11,081 479 (4.3) 
9† London 4 1 8,167 406 (5.0)
14† Somerset 2 1 4,293 287 (6.7)
15 Somerset 5 2 7,218 499 (6.9)
17 Somerset 5 1 8,232 454 (5.5)
18 Bristol 7 2 8,875 699 (7.9)
20 Nottinghamshire 5 3 8,963 645 (7.2)
22 Kent 6 1 11,181 729 (6.5)
26 Kent 6 1 11,299 783 (6.9)
27 Kent 6 1 10,942 627 (5.7)
*Active asthma is defined as a coded diagnosis of asthma and a prescription of at least one asthma medication in the previous 12 months.
†Practices recruited through their involvement in the Quality and Outcomes Framework pilot.
Table 2. Characteristics of participating practices
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these patients (4%) had an ACQ score of >1.5 (the threshold above
which patients can be confidently assumed to have inadequately
controlled asthma10). In contrast, an RCP3Q score of 2 or 3 was
recorded for 32 patients of whom only three (9%) had an ACQ score
of <0.75 (the threshold below which patients can be confidently
assumed to have well controlled asthma10). Thus, in practice, a zero
RCP3 score effectively rules out poor control and an RCP3 score of 2
or 3 rules out good control. However, an RCP3Q score of 1 is less
able to discriminate: 15 (21%) of the 70 patients with an RCP3Q
score of 1 had an ACQ score of >1.5 (poor control), 37 (54%) had
an ACQ score of <0.75 (good control) and 18 (25%) had scores
between 0.75 and 1.5.
Patterns of RCP3Q response    
Table 5 lists each of the possible permutations of symptoms on the
RCP3Q and shows the mean ACQ score of patients who reported
that pattern. In patients reporting only one symptom (RCP3Q=1),
those with symptoms interfering with sleep had a higher mean ACQ
than those who only experienced daytime symptoms. Of the 14
patients who only reported interference with sleep, six (43%) had an
ACQ score of >1.5 indicating poor control compared with nine of 56
(16%) of those whose only symptom was in the daytime or during
activity. Conversely, applying the lower ACQ threshold of <0.75, 32
of 56 patients (57%) with daytime symptoms or activity limitation
were well controlled compared with five of 14 patients (36%) with
disturbed sleep.
Additional records-based indicators of asthma
severity    
Both the number of reliever inhalers prescribed and the number of
recorded asthma exacerbations in the previous year were associated
with the ACQ score (Spearman’s rho 0.30, p=0.001 and Spearman’s
rho 0.35, p<0.001, respectively) and with the RCP3Q score
(Spearman’s rho 0.28, p=0.003 and Spearman’s rho 0.51, p<0.001).
In view of this, we examined these record-based indicators of severity
in order to see if they added predictive value. Given that an RCP3Q
score of zero effectively ruled out poor control and a score of >2 made
it highly likely, we limited this additional analysis to patients with an
RCP3Q score of 1. These patients were categorised as meeting the
record-based criterion for poor control if, in the last year, they had
either been prescribed >4 reliever inhalers or had >1 recorded
exacerbations. The ACQ score was >1 in 11/25 patients (44%) who
met the record-based criterion and in 15/45 (27%) of those who did
not, suggesting that it added relatively little additional value.
Figure 1.  Flow diagram of Asthma Control Questionnaires
(ACQ) received and the process of pairing with the Royal
College of Physicians three questions (RCP3Q) scores
downloaded from practice computers
12 practices provided with 
360 questionnaires
ACQ questionnaires
returned = 291
Patients with RCP3Qs
extracted from patient
computer records = 916*
ACQ unable to be paired = 152
ACQ with missing identifiers = 7
ACQ with no paired RCP3Q = 127
Duplicate match = 2
Dates of completion not within 
24 hours = 16
Paired ACQ and
RCP3Q = 139
Paired ACQ and RCP3Q with
complete data = 129
Incomplete data = 10
RCP3Q incomplete = 8
ACQ incomplete = 2
*  All  RCP3Q  codes  recorded during the time that the practice
participated in the study were extracted, although many practices only
recruited patients during some clinics
RCP3Q score
0 1 2 3 Total
ACQ score (range)
0–0.9 25 44 4 0 73
1–1.9 2 15 8 4 29
2–2.9 0 8 5 6 19
3–3.9 0 2 2 2 6
4–4.9 0 0 0 1 1
5–6.0 0 1 0 0 1
Total 27 70 19 13 129
ACQ=Asthma Control Questionnaire; RCP3Q=Royal College of Physicians 
three questions.
Table 3. Distribution of RCP3Q and ACQ scores
Figure 2.  Receiver operating curve for the Royal College of
Physicians three questions (RCP3Q) score with the threshold
of Asthma Control Questionnaire (ACQ) score of >1
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Variation between practices  
Figure 3 shows the correlation between RCP3Q and ACQ scores
among patients in each practice. The appearance suggests that, in
two practices (J and L), almost all patients are rated as RCP3Q=1
despite reporting a range of ACQ scores, in some cases indicating
poorly controlled asthma. 
Discussion 
Main findings 
When used and recorded in routine practice, the RCP3Q delivered
results that were broadly correlated with the ACQ although there
was considerable variation between practices. In particular, an
RCP3Q of zero indicated good control as assessed by the ACQ and
an RCP3Q score of 2 or 3 indicated poor control. An RCP3Q score
of 1, which was the most commonly reported score, was less
helpful: only 34% had poor control (defined by ACQ >1), although
those with daytime symptoms only were unlikely to have
unequivocally poor control (ACQ >1.5). Recorded exacerbations
and use of reliever inhalers added little to the predictive value of
the RCP3Q when compared with the ACQ, which suggests that
these parameters reflect different aspects of control. The range of
suitable codes and substantial variability in the coding strategies
between practices made data extraction very difficult.
Strengths and limitations of this study   
The participating practices may not have been representative of the
full range of clinical practice, although the QOF pilot20 recruited a
representative sample of UK practices and additional practices were
recruited within these demographically diverse areas. 
The difficulty in matching questionnaire responses to data
extracted from the electronic health record led to less than half of
returned questionnaires being suitable for analysis, which reduced
the statistical power of the study. As a result, confidence intervals
were wider than anticipated and it was not possible to quantify
variation between practices using linear mixed effects modelling. It
may also have introduced bias, although patients’ demography and
ACQ scores were similar in both matched and unmatched cases. 
In the absence of a standardised coding for the three questions,
the practices had developed their own protocols for recording the
RCP3Q. This may mean that we missed or misinterpreted some
coded responses, although we asked practices how they coded the
data and customised our automated search accordingly (see
Appendix 1, available online at www.thepcrj.org).
Practices invited patients to complete the ACQ after an asthma
review in order to ensure that administration did not influence the
patients’ assessment of their control and how they answered the
RCP3Q during the consultation. We specifically asked practice staff
not to change their normal procedure for asking and recording the
RCP3Q in order to reflect real-life practice, although awareness that
they were participating in a study may have influenced their actions.
In keeping with the concept of a phase IV study21 which aims to
influence the ‘usual’ process as little as possible, we collected
anonymous routinely recorded data from the practices. This meant
that we are unsure how many ACQs were actually handed out, and
cannot account for ACQs that we could not pair with RCP3Qs in the
patients’ electronic health record. Had we dictated procedures more
tightly, we would probably have increased the rate of pairing but
would not have been able to observe real-life practice. 
Interpretation of findings in relation to previously
published work  
Our data illustrate the importance of real-life validation of
Additional analyses
ACQ >1.00* ACQ >1.50† ACQ ≤0.75‡
(Crossover between well Predicting poorly controlled Predicting well controlled
and poorly controlled)
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
RCP3Q=0 0.38 (0.28 to 0.51) 0.97 (0.89 to 0.99)
RCP3Q >1 0.96 (0.88 to 0.99) 0.34 (0.24 to 0.46) 0.97 (0.86 to 0.99) 0.28 (0.20 to 0.38)
RCP3Q >2 0.50 (0.37 to 0.63) 0.94 (0.87 to 0.98) 0.57 (0.41 to 0.71) 0.88 (0.80 to 0.93)
*ACQ score 1.00 is the crossover point between well and poorly controlled asthma.  †ACQ score >1.50 may be assumed to have inadequately controlled asthma. The 
question here is whether RCP3Q >2 or RCP3Q >1 is sensitive enough to detect patients with an ACQ score of >1.50 whilst being specific enough to avoid falsely classifying 
well controlled as poorly controlled.  ‡ACQ score ≤0.75 may be assumed to have well controlled asthma. The key question here is whether RCP3Q=0 is sensitive enough to 
detect patients with an ACQ score of ≤0.5, whilst being specific enough to avoid falsely classifying poorly controlled as well controlled.
ACQ=Asthma Control Questionnaire; RCP3Q=Royal College of Physicians three questions.
Table 4. Sensitivity and specificity of the RCP3Q compared with three different ACQ thresholds10 
Response to ACQ question N Mean ACQ 95% CI 
All negative 27 0.36 0.21 to 0.51
One positive response to:
Daytime symptoms 55 0.84 0.60 to 1.08
Activity limitation 1 0.83 –
Sleep disturbance 14 1.40 0.91 to 1.90
Two positive responses
Daytime + sleep 6 1.64 0.99 to 2.28
Daytime + activities 11 1.53 0.92 to 2.05
Sleep + activities 2 1.75 0.93 to 2.57
All three positive 13 2.55 2.02 to 3.09
ACQ=Asthma Control Questionnaire; RCP3Q=Royal College of Physicians 
three questions.
Table 5. Patterns of response to individual RCP3Q
questions:  prevalence and association with ACQ score
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questionnaires. Compared with the study by Thomas et al. in which
the RCP3Q was administered under research conditions,19 we
observed similar sensitivity (RCP3Q extracted from the routine
records detected 96% of patients with ACQ >1 compared with
94%) but specificity was halved (34% compared with 67%). This
may reflect the explicit 1-week timescale applied in the research
context compared with a relatively open-ended approach used to
assess control in real life which would be more likely to capture a
recent episode of poor control.   
The observed heterogeneity between practices probably reflects
procedural variations. Although some clinicians may administer the
questions precisely as described in the literature, others may
paraphrase the questions or introduce them informally into the
conversation and record the answers at the end of the consultation.
Some practices may adopt practical strategies such as sending out
questionnaires some weeks in advance with an invitation to attend
for a review (potentially misleading in a variable condition such as
asthma). Clinicians will find pragmatic ways to administer
questionnaires to people (often excluded in research studies) with
poor literacy, reduced vision, or who ‘cannot answer a questionnaire
in English’. The variation is further compounded when choice exists
in coding systems. Similar variation in other disease contexts (e.g. the
nine-item Patient Health Questionnaire which assesses severity of
depression22) raised concerns that the questionnaire performed
inconsistently in real-life practice.23
Qualitative research after the PHQ9 was included in QOF in 2006
suggested that, despite general practitioners’ caution about using
formal questionnaires, patients’ confidence in their general
practitioners’ assessment and management of their mental health
problems increased.24 In contrast, the RCP3Q was generally well
accepted by professionals in the pilot work,6 reflecting the emphasis
– recently prioritised in the International Primary Care Respiratory
Group’s research needs prioritisation exercise – on simple
questionnaires (or ‘questions’) to assist with clinical assessment in
the typically low technological environment of primary care.25
Previous studies of the validity of the RCP3Q in the context of
research concluded that ‘any positive responses may indicate
suboptimal control’ whereas our findings suggest that the presence
of daytime symptoms was compatible with good control as judged
by an ACQ score of <0.75. This resonates with definitions of control
in international and national guidelines which distinguish between
occasional daytime symptoms (e.g. on ≤2 days a week) which may
be ‘acceptable’ in a well-controlled patient whilst any nocturnal
waking should be considered as less than well controlled and
management adjusted accordingly.26,27 Modelling of similar morbidity
questions in the context of a large-scale audit of asthma
management concluded that the RCP3Q provided an effective
assessment of control but that a version which incorporated
frequency of symptoms was more sensitive to poor control.15
Including exacerbations and use of reliever inhalers as indicators
of poor control added little to the predictive power of the RCP3Q in
relation to the ACQ. This may be because both the questionnaires
measure morbidity at one point in time whereas exacerbation and
use of short-acting β2-agonists could reflect previous episodes of
poor control which may have resolved at the time of a review.
Exacerbations and prescribing history are normally readily available
to primary care clinicians, and our data reinforce recommendations
that all aspects of present control and future risk should be
considered when assessing asthma control.1,3
Implications for future research, policy and practice  
The clinical implications of our findings are summarised in Table 6.
The RCP3Q scores have clinical utility although they should be
interpreted in the light of the broader clinical context – especially
scores of 1. Many developers of questionnaires express the hope
that their instrument will be of value in the clinical context,9,28 and
the potential of alternative instruments for measuring asthma
control in routine asthma reviews has been summarised by the
International Primary Care Respiratory Group.29 However, clinical
utility is not the same as validation in a research context, and the
significant variation we observed between practices emphasises the
need for real-life phase IV assessment before tools are introduced
into routine clinical practice.30 Provision of a single suitable coding
system could remove one source of variability.  
Figure 3.  Scatter plots of the Royal College of Physicians
three questions (RCP3Q) score against the Asthma Control
Questionnaire (ACQ) score for each practice
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RCP3Q score Interpretation 
0 Good control
1 (daytime symptoms only) Compatible with good control, though may 
be indicative of poor control in some 
patients
1 (sleep disturbance or Likely to be poorly controlled and needs 
activity affected) further assessment
2 Poor control
3
Exacerbations and use of reliever inhalers reflect a different aspect of 
control and should be explored independently
Table 6. Interpretation of the Royal College of Physicians
three questions (RCP3Q) scores in clinical practice
ACQ Score
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Conclusions   
Our data support the promotion of the RCP3Q as a practical tool for
detecting suboptimal current control when used in routine asthma
reviews and offers advice on how scores obtained in real-life
practice should be interpreted. Taken in conjunction with
exacerbations and use of reliever inhalers, routine adoption of these
simple morbidity questions could contribute to addressing the
recognised challenge of improving asthma control.  
Handling editor Niels Chavannes
Statistical review Gopal Netuveli
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Practice ID Activity Sleep Symptoms
These practices selected codes from the series 663
663    Asthma sometimes restricts exercise 663r Asthma causes night symptoms 663  Asthma sometimes restricts exercise
663e   Asthma restricts exercise 1 or 2 times a month 663q  Asthma daytime symptoms
663f    Asthma never restricts exercise 663N Asthma disturbing sleep 663s  Asthma never causes daytime symptoms
663w    Asthma limits walking up hills or stairs 663N0  Asthma causing night waking 663t   Asthma causes day symptoms
663x    Asthma limits walking on the flat 663N1  Asthma disturbs sleep weekly 1 or 2 times a month
663P   Asthma limiting activities 663N2  Asthma disturbs sleep frequently 663u  Asthma causes daytime symptoms
663Q   Asthma not limiting activities 663O   Asthma not disturbing sleep 1 or 2 times per week 
663x    Asthma limits walking on the flat 663O0  Asthma never disturbs sleep 663v  Asthma daytime symptoms most days
6635  Increasing exercise wheeze 66YP  Asthma night time symptoms
This practice used V3 Read codes and specified specific symptoms or activity limitation
20 XE0qn  Cough 663N2  Asthma disturbs sleep frequently X7A2S   Housework
Xa7uu   Expiratory wheeze 663N1  Asthma disturbs sleep weekly X79so   School
Xa7ut   Inspiratory wheeze 663O  Asthma not disturbing sleep Xa83v  Unable to undertake job application 
Y5925  Chest tightness activities
173Z   Breathlessness Xa7he   Difficulty engaging in a hobby
XaINa Asthma never causes daytime symptoms
These practices used few codes, but annotated the free text with the number of days per week affected.  Any days affected was interpreted as a ‘yes’ 
response, if no days were affected the response was ‘no’.  
22, 26, 27 663P     Asthma limiting activities 663N   Asthma disturbing sleep 663q   Asthma daytime symptom
Appendix 1  Coding conventions for the RCP3Qs in the participating practices
Practices
involved in
the QOF
pilot:
1,2,5,9,14.
Other
practices:
15,17,
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